MedPath

The impact of Florabile syrup on intensity of Psoriasis rashes.

Phase 1
Conditions
Psoriasis.
Psoriasis
Registration Number
IRCT20200408047000N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
25
Inclusion Criteria

The patient must be between 20 to 50 years old.
Patients should have mild to moderate Psoriasis and their body should be involved less than 20%.
If patient has taken any other drugs to treat Psoriasis, he or she should not consume new dug for three months.

Exclusion Criteria

Patients with generalized, unstable, or pustular Psoriasis who have only skull, nails, flexor surfaces or palms and soles involvement.
Patients who are pregnant or breastfeeding.
Patients who are allergic to plums, jujube, and Tamarindus indica-derived products.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Suitable (PASI; Psoriasis Area Severity Index) for any patient. Timepoint: At the beginning of the study (Before intervention) and after finishing the study. Method of measurement: The software of calculating Psoriasis Severity Area Index. Version 1.7.2.;Percent of patients body surface involved (BSA; Body Surface Area). Timepoint: At the beginning of the study (Before intervention) and after finishing the study. Method of measurement: Calculating formula of the Percent of patients body surface involved.;Erythema (redness) of Psoriasis rashes. Timepoint: At the beginning of the study (Before intervention) and after finishing the study. Method of measurement: Observation.;Induration (plaque) of Psoriasis rashes. Timepoint: At the beginning of the study (Before intervention) and after finishing the study. Method of measurement: Observation.;Desquamation (scaling) of Psoriasis rashes. Timepoint: At the beginning of the study (Before intervention) and after finishing the study. Method of measurement: Observation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath